跳至主要内容
临床试验/NL-OMON37417
NL-OMON37417已完成不适用

The efficacy of pro- and anticoagulant therapy in plasma from patients with liver cirrhosis . - EPAC

niversitair Medisch Centrum Groningen0 个研究点目标入组 126 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria study group:
  • - Cirrhosis
  • - >18 year
  • - Signed informed consent
  • Inclusion criteria healhty control group
  • - >18 year
  • - Signed informed consent

排除标准

  • Exclusion criteria study group:
  • - Congenital coagulation disorder
  • - Active infection
  • - Acute liver failure
  • - Use of anticoagulant drugs in the past 10 days
  • - Pregnancy
  • - (<7 days) transfusion with blood products;Exclusion criteria control-group
  • - Documented history of congenital coagulation disorder
  • - History of vascular disease
  • - History of hepatic disease
  • - History of any systemic disease
  • - Recent viral infection (>2 weeks)
  • - Use of anticoagulant drugs in the past 10 days
  • - Pregnancy

研究者

相似试验

The efficacy of pro- and anticoagulant therapy in... | 临床试验